<DOC>
	<DOC>NCT00428051</DOC>
	<brief_summary>The study will determine the reduction in invasive pneumococcal disease (IPD) after the introduction of a National Immunization Program with PCV-7 in Bogota. The original LEAP study determine incidence of IPD prior to introduction of PCV-7 in Brazil, Costa Rica and Colombia. LEAP II is the continuation of the study in Colombia only.</brief_summary>
	<brief_title>Colombia Epidemiologic Surveillance Study</brief_title>
	<detailed_description>The study was stopped based on a decision to include PCV 10 in the National Immunization Program in Colombia. The study was designed to measure the impact of PCV 7 and 13 and is no longer feasible.</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<criteria>Children 28 days to 36 months of age Presenting to a participating facility with a measured temperature of 39 degrees C or higher within 24 hours prior to screening, or with clinical suspicion of pneumonia, meningitis, bacteremia, sepsis, or other invasive pneumococcal disease Any patient hat based on the clinical impression of the treating physician should not participate in the study: examples such as those with suspected dengue or urinary tract infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Epidemiology</keyword>
	<keyword>Surveillance</keyword>
	<keyword>Streptococcal Pneumonia</keyword>
</DOC>